Publications list for Professor Mathew Vadas

2011 | 2010 | 2009 | 2008 | 2007 | 2006

2011

   
  • Gamble, J., Vadas, M., McCaughan, G. (2011), Sinusoidal endothelium is essential for liver regeneration. Hepatology. 54(2), 731-733. [Abstract]

2010

   
  • Coleman, P., Hahn, C., Grimshaw, M., Lu, Y., Li, X., Brautigan, P., Beck, K., Stocker, R., Vadas, M., Gamble, J. (2010), Stress-induced premature senescence mediated by a novel gene, SENEX, results in an anti-inflammatory phenotype in endothelial cells. Blood. 116(19), 4016-24. [Abstract]
  • Williams, S., Milne, I., Bagley, C., Gamble, J., Vadas, M., Pitson, S., Khew-Goodall, Y. (2010), A proinflammatory role for proteolytically cleaved annexin A1 in neutrophil transendothelial migration. Journal of Immunology. 185(5), 3057-3063. [Abstract]

2009

   
  • Gamble, J., Sun, W., Li, X., Hahn, C., Pitson, S., Vadas, M., Bonder, C. (2009), Sphingosine kinase-1 associates with integrin {alpha}V{beta}3 to mediate endothelial cell survival. The American Journal of Pathology. 175(5), 2217-2225. [Abstract]
  • Sukocheva, O., Wang, L., Verrier, E., Vadas, M., Xia, P. (2009), Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology. 150(10), 4484-4492. [Abstract]
  • Li, X., Stankovic, M., Lee, B., Aurrand-Lions, M., Hahn, C., Lu, Y., Imhof, B., Vadas, M., Gamble, J. (2009), JAM-C Induces Endothelial Cell Permeability Through Its Association and Regulation of {beta}3 Integrins. Arteriosclerosis, thrombosis, and vascular biology. 29(8), 1200-6. [Abstract]
  • Bonder, C., Sun, W., Matthews, T., Cassano, C., Li, X., Ramshaw, H., Pitson, S., Lopez, A., Coates, P., Proia, R., Vadas, M., Gamble, J. (2009), Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation. Blood. 113(9), 2108-2117. [Abstract]
  • Gamble, J., Vadas, M. (2009), Insights into defibrotide as therapy for veno-occlusive disease. Hepatology. 49(2), 689-690. [Abstract]
  • Limaye, V., Xia, P., Hahn, C., Smith, M., Vadas, M., Pitson, S., Gamble, J. (2009), Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cellular & Molecular Biology Letters. 14(3), 424-441. [Abstract]
  • Limaye, V., Vadas, M., Pitson, S., Gamble, J. (2009), The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells. Cellular & Molecular Biology Letters. 14(3), 411-423. [Abstract]

2008

   
  • Vadas, M., Xia, P., McCaughan, G., Gamble, J. (2008), The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?. Biochimica et biophysica acta. 1781(9), 442-7. [Abstract]
  • Gregory, P., Bert, A., Paterson, E., Barry, S., Tsykin, A., Farshid, G., Vadas, M., Khew-Goodall, Y., Goodall, G. (2008), The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature cell biology. 10(5), 593-601. [Abstract]
  • Leclercq, T., Moretti, P., Vadas, M., Pitson, S. (2008), Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. The Journal of biological chemistry. 283(15), 9606-14. [Abstract]
  • Li, X., Stankovic, M., Bonder, C., Hahn, C., Parsons, M., Pitson, S., Xia, P., Proia, R., Vadas, M., Gamble, J. (2008), Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. Blood. 111(7), 3489-3497. [Abstract]

2007

   
  • Soldi, R., Mandinova, A., Venkataraman, K., Hla, T., Vadas, M., Pitson, S., Duarte, M., Graziani, I., Kolev, V., Kacer, D., Kirov, A., Maciag, T., Prudovsky, I. (2007), Sphingosine kinase 1 is a critical component of the copper-dependent FGF1 export pathway. Experimental cell research. 313(15), 3308-18. [Abstract]

2006

   
  • Hissaria, P., Smith, W., Wormald, P., Taylor, J., Vadas, M., Gillis, D., Kette, F. (2006), Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. The Journal of allergy and clinical immunology. 118(1), 128-33. [Abstract]
  • Bert, A., GrĂ©pin, R., Vadas, M., Goodall, G. (2006), Assessing IRES activity in the HIF-1alpha and other cellular 5' UTRs. RNA. 12(6), 1074-1083. [Abstract]
  • Gamble, J., Xia, P., Hahn, C., Drew, J., Drogemuller, C., Brown, D., Vadas, M. (2006), Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects. International journal of cancer. Journal international du cancer. 118(10), 2412-2420. [Abstract]
  • Sutherland, C., Moretti, P., Hewitt, N., Bagley, C., Vadas, M., Pitson, S. (2006), The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane. The Journal of biological chemistry. 281(17), 11693-701. [Abstract]
  • Sukocheva, O., Wadham, C., Holmes, A., Albanese, N., Verrier, E., Feng, F., Bernal, A., Derian, C., Ullrich, A., Vadas, M., Xia, P. (2006), Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. The Journal of cell biology. 173(2), 301-10. [Abstract]
  • Autelitano, D., Rajic, A., Smith, A., Berndt, M., Ilag, L., Vadas, M. (2006), The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug discovery today. 11(7-8), 306-14. [Abstract]